logo
▶ About us
▶ News & Events
▶ For Physicians
▶ How you can help
▶ Site Map
Sign up for our mailing list!
 
Visit our Facebook page
 
The Benefits of Exercise
 
New Fetal Transplant Study
 
Thalassemia Adoption Clinic
 
 
 
 
 
Sign up for our newsletter
 
Story of an Alpha Thalassemia Baby


Treating Thalassemia

Treating Thalassemia
▶ DNA Testing
▶ Transfusion
▶ Chelation
    » Introduction
    » Desferal
        --Desferal guide
    » Exjade
    » L1
    » Combination
▶ Iron and the Pituitary Gland
▶ Splenectomy
▶ Thromboembolic disease
▶ Hemoglobin H disease:
    » Overview
    » Guidelines
▶ Iron Measurement
▶ SQUIDS Across the Globe
▶ Bone Health
▶ Evaluation timetable
▶ Bone marrow transplant
    » HLA genetics
    » BMT factsheet
▶ Hydroxyurea
▶ Standard of Care Guidelines (2012)
▶ Non-transfusion-dependent thalassemia: TIF guidelines
▶ Non-transfusion-dependent thalassemia: Review
Thalassemia Standard-of-Care Guidelines
(mobile optimized)
SOC QR
▶ Intrauterine Therapy for Alpha Thal Major


▶ Fetal Transplant Study
Thalassemia Management Checklists
PDF brochures:
    » Managing Transfusion Therapy
    » Monitoring Iron Overload in TDT
    » Monitoring Deferasirox Therapy

Thalassemia specialty care centers in the Western United States

Thalassemia Management Checklists
by Ashutosh Lal, MD

Accessing the TMCs:

There are currently three TMCs available, which discuss the following topics:

1. Managing Transfusion Therapy
2. Monitoring Iron Overload in TDT
3. Monitoring Deferasirox Therapy

Hematologists, patients, and families can access printed copies of the TMCs from Thalassemia Treatment Centers, such as ours. They can also download electronic copies from thalassemia websites like: www.thalassemia.com.

Thalassemia Management Checklists were developed in collaboration with the UCSF Benioff Children's Hospital Oakland, the Weill Cornell Medical Center, the Children's Hospital of Philadelphia, and the Cooley's Anemia Foundation.

The Thalassemia Western Consortium is a regional network of 11 thalassemia centers across the West Coast. The Consortium aims to establish collaborative thalassemia standards of care, collect data on thalassemia services and outcomes, and reach hematologists outside of their group. The Consortium met in November 2018 for its fourth annual meeting in San Diego, CA.

Quick reference guides to reduce disparities in the care of patients with transfusion-dependent thalassemia
By Ashutosh Lal, MD

The prevalence of thalassemia in the United States is rising due to immigration, new births, adoptions, and improved survival. Advances in monitoring and treatment have significantly reduced morbidity and mortality in transfusion-dependent thalassemia (TDT).

Thalassemia Treatment Centers (TTCs) utilize a comprehensive care model to provide contemporary care. But, a majority of the patients with TDT are not managed at such centers owing to long travel distance and lack of insurance portability. Lack of access to specialized care increases the risk of complications, shortens survival, and reduces health-related quality of life.

Recently, there has been a national effort to standardize management of TDT and reduce disparities in access to and quality of care. This effort has been led in part by the multi-site Thalassemia Western Consortium, which held its fourth annual meeting in November 2018.

The backbone of the initiative to reduce disparities in quality of care for TDT has been the development of Thalassemia Management Checklists (TMCs), a set of quick reference guides that provide decision support to physicians managing TDT. Physicians are more likely to consult a quick reference guide -- such as these -- instead of textbooks, journals, or handbooks of comprehensive guidelines. TMCs cover most routine management of TDT while encouraging expert consultation for complex decisions.

The final product is in the form of three separate documents, each covering a single topic -- thus allowing easy access to the summary information while displaying detailed information on demand. Over the next three years, adoption of TMCs and their impact on patient care will be formally evaluated in selected regions. Patient access to TMCs will increase knowledge and promote self-advocacy.

Designing the TMCs

Each checklist has three sections:

  1. Summary table with essential information
  2. Literature review and rationale for the recommendations
  3. Bibliography of citations made available with a link provided in the TMCs

Updated 1/28/2019


Northern California Comprehensive Thalassemia Center
UCSF Benioff Children's Hospital Oakland
747 52nd Street, Oakland CA 94609   •   Phone: (510) 428-3651   •   Fax: (510) 450-5647
© 2003-2012 Children's Hospital & Research Center Oakland
Facebook logo Twitter logo Youtube logo Blogger logo
| Home | Our Program | Contact Us | For physicians | What is thalassemia? | Genetics | Treatment | Research | Living with thalassemia | Site Map |